Moderna CEO Stéphane Bancel, a veteran biotech executive whose ...
Synopsis by Forbes May 24 22
Moderna CEO Stéphane Bancel, a veteran biotech executive whose fortune swelled during the Covid-19 pandemic, revealed he would donate all the after-tax ...Read full article
Forbes: Moderna CEO Stéphane Bancel, a veteran biotech executive whose ...
Story Details
| Last Updated | May 24 22 |
| Total Articles | 3 |
Main Topics
respiratory syndrome and infectious disease in humans, caused by SARS coronavirus 2
News on this topic
Billionaire Moderna CEO Stéphane Bancel Pledges Stock Options Worth $355 Million To Undisclosed Charitable Causes
forbes.com/sites/jonathanponciano/2022/05/24/billionaire-moderna-ceo-stphane-bancel-pledges-stock-options-worth-355-million-to-undisclosed-charitable-causes/
Moderna CEO Stéphane Bancel, a veteran biotech executive whose fortune swelled during the Covid-19 pandemic, revealed he would donate all the after-tax ... Show more https://trib.al/ZgOv8cK
More news on this subject
Previous
Billionaire Moderna CEO Stéphane Bancel Pledges Stock Options Worth $355 Million To Undisclosed Charitable Causes
forbes.com/sites/jonathanponciano/2022/05/24/billionaire-moderna-ceo-stphane-bancel-pledges-stock-options-worth-355-million-to-undisclosed-charitable-causes/
China's drugmakers can't sell mRNA shots but haven't quit yet: China's vaccine developers stuck with unused mRNA COVID shots and idle manufacturing plants are ...
reuters.com/business/healthcare-pharmaceuticals/chinas-drugmakers-cant-sell-mrna-shots-havent-quit-yet-2024-04-19/
Moderna Pauses mRNA Plant Plans in Kenya After $1 Billion loss: Moderna Inc. has paused its efforts to build an mRNA manufacturing facility in Kenya while it ...
bloomberg.com/news/articles/2024-04-11/moderna-pauses-mrna-plant-plans-in-kenya-after-1-billion-loss
Paid articlePaid
Moderna pauses Kenya plant plans as COVID vaccine demand wanes: Moderna said on Thursday it had paused its plans to build a vaccine manufacturing facility in ...
reuters.com/business/healthcare-pharmaceuticals/moderna-puts-kenya-plant-plans-hold-covid-vaccine-demand-slumps-2024-04-11/
Pfizer wins pause on Moderna's COVID-19 patent lawsuit: Moderna's patent lawsuit claiming Pfizer and BioNTech copied its COVID-19 vaccine technology will be put ...
reuters.com/legal/litigation/pfizer-wins-pause-modernas-covid-19-patent-lawsuit-2024-04-12/
Moderna jumps as vaccine shows benefit in head and neck cancer in early study: Moderna shares rose 8% to a three-month high on Tuesday after the company's ...
reuters.com/markets/us/moderna-jumps-personalized-cancer-vaccine-shows-benefit-early-study-2024-04-09/
State-of-the-Art Care in Amyotrophic Lateral Sclerosis: Improving Diagnostic Accuracy and Therapeutic Efficacy
medscape.org/viewarticle/999480
Nicole Shanahan, RFK Jr.’s Running Mate, Sets New Low for Anti-Vax Misinformation
thedailybeast.com/nicole-shanahan-rfk-jrs-running-mate-sets-new-low-for-anti-vax-misinformation
Paid articlePaid Moderna shares fall after judge sides with Arbutus in patent fight: Shares of Moderna fell 4% on Wednesday after a U.S. judge issued an order that strengthened ...
reuters.com/legal/moderna-shares-fall-after-judge-sides-with-arbutus-patent-fight-2024-04-03/
Were COVID-19 Vaccines to Blame for Infertility? Heart Attacks? A New Report Weighs In
usnews.com/news/health-news/articles/2024-04-16/were-covid-19-vaccines-to-blame-for-infertility-heart-attacks-a-new-report-weighs-in
Biontech: “Moderna has a one to two year lead when it comes to cancer drugs”: Biontech is working on over twenty drugs against cancer. The doctor and fund ...
wiwo.de/unternehmen/industrie/biontech-das-wuerde-ein-neues-zeitalter-in-der-krebstherapie-einleiten/29750834.html
Quick Glance: Innovative Cancer Therapy: Biontech's Advancement
- Biontech is actively developing over twenty cancer medications with promising results.
- Current developments and potential market introductions of cancer treatments.
- Significance of Biontech's promising results against pancreatic cancer.
The Dow drops 300 points as investors get jittery about inflation: Economists expect the consumer price index to increase from February
qz.com/dow-jones-industrial-average-inflation-fed-interest-rat-1851397283
The Dow struggles to recover as investors anxiously await inflation data — and the Fed
qz.com/dow-jones-inflation-report-consumer-price-index-1851398195
Weight-loss drug startup Metsera wants to take on Novo and Lilly. Here’s what you need to know
fastcompany.com/91110090/metsera-startup-eli-lilly-novo-nordisk-competitor-weight-loss-drugs
The top companies for training workers to use AI — including Amazon and GM: A new report reveals which firms are doing the most to advance AI literacy both ...
qz.com/amazon-gm-jpmorgan-moderna-ai-workforce-training-1851411624
Activist investor blasts Novavax for not using mRNA fears to boost COVID-19 vaccine sales
qz.com/novavax-covid19-mrna-1851410267
Quick Glance: Criticism of Novavax for Missed Opportunities in Boosting COVID-19 Vaccine Sales
- Shah Capital called for immediate changes in the company's board.
- The activist hedge fund Shah Capital criticized Novavax's leadership for not capitalizing on concerns some individuals have about mRNA vaccines to increase sales of its traditional, protein-based COVID-19 vaccine.
- Findings from a survey of 1,500 Americans by the Annenberg Public Policy Center (APPC) at the University of Pennsylvania revealed an increase in the spread of vaccine misinformation.
- The limited use of COVID-19 vaccines is also affecting other vaccine manufacturers. In the U.S., only 14% of adults have received an updated COVID-19 vaccine for 2023-2024, according to the Centers for Disease Control and Prevention.
5 Cheap Stocks Leading the Low-Carbon Transition: Moderna, Etsy, Illumina, Healthpeak Properties, and PayPal Holdings are trading below their fair value ...
morningstar.com/sustainable-investing/5-cheap-stocks-leading-low-carbon-transition
Gain a better understanding of the technology shaping the future of the health and biotech industry when you sign up for our free weekly newsletter ... Show more
Philly area biotech is worried about Congress’ crackdown on Chinese manufacturers
inquirer.com/business/philadelphia-biotech-congress-china-manufacturing-gene-cell-therapy-20240416.html
Moderna's new cancer vax, AstraZeneca CEO's big pay, and record-high drug shortages: Pharma news round up
qz.com/moderna-cancer-vax-astrazeneca-ceo-pay-drug-shortages-1851404812
Moderna: Considering The Cancer Vaccine Angle: Moderna is developing a vaccine-based treatment for solid tumors. Read why I would not say that the oncology ...
seekingalpha.com/article/4683290-moderna-considering-the-cancer-vaccine-angle
Paid articlePaid
Markets in the morning: Moderna, Enphase, Rheinmetall, Daimler Truck, Vonovia, BP, Nordex, Nel, Freyr
Moderna’s stock up 6% as its cancer vaccine could treat more than just melanoma: Data shows a better overall survival rate for head and neck cancer in ...
marketwatch.com/story/modernas-stock-jumps-6-as-its-cancer-vaccine-could-treat-more-than-just-melanoma-92c8a45f
Reshape wants to help ‘decode nature’ by automating the ‘visual’ part of lab experiments
techcrunch.com/2024/04/09/reshape-wants-to-accelerate-biotech-rd-by-bringing-computer-vision-to-lab-experiments/
Mega potential: Will this biotech stock be as big as BioNTech and Moderna in their heyday?
boerse-online.de/nachrichten/aktien/mega-potenzial-wird-diese-biotech-aktie-so-gross-wie-biontech-und-moderna-zu-ihren-besten-zeiten--20354243.html
Influenza and coronavirus: one step closer to a combined vaccine: Moderna has been working for some time on the possibility of developing a vaccine that is ...
diepresse.com/18326862/influenza-und-corona-virus-einem-kombinierten-impfstoff-ein-stueck-naeher
Quick Glance: Advances in Combined Influenza and Covid-19 Vaccine
- Moderna progresses in developing a combined vaccine for Influenza and Covid-19.
- New Sars-CoV-2 vaccine elicits stronger immune response than current one.
- Study shows enhanced immune response in individuals over 65 years.
- Focus on targeted antibodies and extended vaccine shelf life in development.
Blackstone cures two ailments in one Moderna shot: Lending to a company is fine; taking a piece of its most promising investments is better ...
reuters.com/breakingviews/blackstone-cures-two-ailments-one-moderna-shot-2024-03-27/
The Best Biotech Stocks to Buy: Thanks to rapid innovation and strong product launches, some biotech stocks look attractive again.
morningstar.com/stocks/best-biotech-stocks-buy
Moderna Stock Pops as New Covid-19 Vaccine Shows Positive Results: Moderna’s ‘next generation,’ Covid-19 vaccine has shown a higher immune response to the virus ...
barrons.com/articles/moderna-stock-pops-price-vaccine-55ef1af0
Paid articlePaid Moderna Gets $750 Million for Flu Program. Funding to Help Move Beyond Covid Vaccines.
on.barrons.com/43Csi93
Transcript: Moderna's CFO on What a Biotech Company Does with $13 Billion: Allocating Capital on a long and uncertain timeline
bloomberg.com/news/articles/2024-03-11/transcript
Paid articlePaid
Is Cathie Wood Buying The Rumor? Ark More Than Doubles Stake In This COVID-19 Vaccine Maker Ahead Of Flur
benzinga.com/general/biotech/24/03/37864820/is-cathie-wood-buying-the-rumor-ark-more-than-doubles-stake-in-this-covid-19-vaccine-maker-ahead-
Ozempic's cheaper side, weight loss drug competition, and Amazon delivery: Pharma news roundup
qz.com/ozempic-weight-loss-drug-amazon-delivery-novo-nordisk-1851373018
Paid articlePaid Moderna’s Earnings Surprised the Street. Why One Analyst Says to Sell.: HBSC downgraded the vaccine maker to Reduce from Hold in a Monday report.
barrons.com/articles/moderna-stock-rsv-downgrade-cdc-6efafb59
Paid articlePaid Nvidia, Walmart, Moderna, Block, Newmont, and More Stocks to Watch This Week: The market is closed for Presidents Day on Monday. Then, Nvidia earnings ...
barrons.com/articles/nvidia-walmart-moderna-block-newmont-stocks-earnings-76eb184e
Paid articlePaid Moderna reports surprise profit, sets out road map for RSV vaccine: Moderna on Thursday reported a surprise fourth-quarter profit, helped by cost cutting and ...
reut.rs/49KcUcy
Covid vaccines linked to rare heart and brain disorders, says vaccine study: A recent peer-reviewed study has revealed rare occurrences of heart, brain ...
iol.co.za/news/world/covid-vaccines-linked-to-rare-heart-and-brain-disorders-says-vaccine-study-b3ab0442-ee5d-45c3-bc84-7fd99049d9a4
A plan to bring down drug prices could threaten America’s technology boom: As it stands, the draft policy would undermine the long-standing Bayh-Dole Act ...
technologyreview.com/2024/03/08/1089592/a-plan-to-bring-down-drug-prices-could-threaten-americas-technology-boom/
Moderna’s RSV Vaccine May Lose Efficacy Faster Than GSK and Pfizer’s: Moderna shares were falling after the biotech revealed data that might hurt its vaccine’s ...
barrons.com/articles/moderna-stock-price-rsv-vaccine-b5d93bf3
Paid articlePaid Ozempic's cheaper side, weight loss drug competition, and Amazon delivery: Pharma news roundup
qz.com/ozempic-weight-loss-drug-amazon-delivery-novo-nordisk-1851373018
Paid articlePaid
Closing bell: US stock markets turn up at the end of trading, Moderna accelerates - Merck & Co at the top of the Dow
deraktionaer.de/artikel/maerkte-forex-zinsen/schlussglocke-us-boersen-drehen-zum-handelsende-auf-moderna-gibt-gas-merck-co-an-dow-spitze-20353982.html
Moderna Is Pivoting From Covid—the Results Are on Their Way: An approved RSV vaccine on the market this year looks likely, but investors worry about efficacy.
on.wsj.com/3wtrR4I
DAX in record mode: SMA Solar, Rheinmetall, Renk, Moderna, Deutsche Bank, SGL and Airbus in focus
deraktionaer.de/artikel/indizes/dax-im-rekordmodus-sma-solar-rheinmetall-renk-moderna-deutsche-bank-sgl-und-airbus-im-fokus-20353876.html
Does she know more? Star investor Cathie Wood has just signed up for this BioNTech competitor
boerse-online.de/nachrichten/aktien/weiss-sie-mehr-bei-diesem-biontech-konkurrent-hat-cathie-wood-gerade-zugeschlagen-20353621.html
If tech runs out of steam: That's why stocks from BioNTech and Co. are also exciting for investors
boerse-online.de/nachrichten/zertifikate/falls-tech-die-luft-ausgeht-darum-sind-auch-aktien-von-biontech-und-co-fuer-anleger-spannend-20353073.html
Gilead-backed biotech Kyverna's shares surge over 50% in stellar debut: Shares of Kyverna Therapeutics (KYTX.O) jumped 55.7% in their market debut on Thursday ...
reuters.com/markets/deals/gilead-backed-kyverna-therapeutics-valued-14-bln-stellar-debut-2024-02-08/
Quick Glance: Netanyahu Rejects Hamas Ceasefire, Pursues Total Victory
- Netanyahu says total victory in Gaza is within reach, rejecting the latest offer from Hamas for a ceasefire to ensure the return of hostages.
- He renews a pledge to destroy the Palestinian Islamist movement, insisting that total victory is the only solution to the Gaza war.
- Hamas had proposed a ceasefire of four-and-a-half months, during which all hostages would go free and Israel would withdraw its troops from the Gaza Strip.
- A Hamas delegation would travel to Cairo on Thursday to pursue ceasefire talks with the mediators Egypt and Qatar.
International Women's Day 2024: 5 most influential women CEOs in India: In India, women CEOs drive businesses forward. Let's celebrate some exceptional ones this ...
hindustantimes.com/photos/lifestyle/international-womens-day-2024-5-most-influential-women-ceos-in-india-101709639772210.html
The UK could be a vaccine superpower, but it needs a booster: We risk forgetting the lessons of the Covid pandemic
ft.com/content/77f1be71-dc25-48df-8f9a-f677e2cf07a6
Paid articlePaid Moderna shares accelerate: That's the reason: That inspires you to start the week.
deraktionaer.de/artikel/pharma-biotech/moderna-aktie-gibt-maechtig-gas-das-ist-der-grund-20352636.html
Cancer vaccines could be ‘dawn of a new age’ of treatments says Moderna chief: Dr Kyle Holen said he is excited about the future direction of treating the ...
inews.co.uk/news/cancer-vaccines-could-be-dawn-of-a-new-age-of-treatments-says-moderna-chief-2888584
Layoffs are plaguing the healthcare industry, too: Job cuts have hit Pfizer, Amazon Health Services, local hospitals, and biotech startups so far in 2024
qz.com/healthcare-industry-layoffs-pfizer-amazon-health-1851231629
Paid articlePaid
Brand-new Moderna mRNA vaccine for cancer being trialled in Britain: British patients are trialling a new mRNA-4359 vaccine as part of a clinical trial which ...
chroniclelive.co.uk/news/health/brand-new-moderna-mrna-vaccine-28567561
China's Wuxi AppTec says it should not be 'company of concern' in draft US biotech bill
reuters.com/business/healthcare-pharmaceuticals/chinas-wuxi-apptec-says-it-should-not-be-company-concern-draft-us-biotech-bill-2024-02-04/
Hamburg doctors see breakthrough in anti-cancer syringe: Biontech's coronavirus vaccine is being prepared for a syringe in a doctor's surgery in Hamburg (archive ...
abendblatt.de/hamburg/politik/article241761192/Hamburger-Aerzte-sehen-Durchbruch-bei-Spritze-gegen-Krebs.html
Paid articlePaid
What is lab-grown meat, and why does Ron DeSantis want to ban it in Florida?: Proposed legislation would prohibit the sale of lab grown meat from being sold in ...
miamiherald.com/news/politics-government/state-politics/article285829481.html
Pharmaceutical industry: Moderna makes billions in losses, but the shares are rising
handelsblatt.com/unternehmen/industrie/pharma-branche-moderna-macht-milliardenverlust-doch-die-aktie-steigt/100017428.html
Moderna will supply COVID-19 vaccines made in Laval by fall 2025: The plant, whose construction was just completed, will be able to produce 100 million doses of ...
montrealgazette.com/news/local-news/moderna-will-supply-covid-19-vaccines-made-in-laval-by-fall-2025
Paid articlePaid DAX reaches new all-time high according to Nvidia figures, Nikkei with new record: SAP, MTU, Heidelberg Materials, SFC Energy, Gerresheimer, Mercedes-Benz ...
deraktionaer.de/artikel/indizes/dax-nach-nvidia-zahlen-vor-neuem-allzeithoch-nikkei-mit-neuem-rekord-sap-mtu-heidelberg-materials-sfc-energy-gerresheimer-mercedes-benz-moderna-und-hochtief-im-fokus-das-ist-heute-wichtig-20351077.html
Bloomberg New Economy: Cutting China Out of Biotech Unifies US Parties: Four years after Covid-19 first appeared in China, Washington is assembling a plan to ...
bloomberg.com/news/newsletters/2024-02-17/bloomberg-new-economy-cutting-china-out-of-biotech-unifies-us-parties
Awesome trading week ahead: Despite a shortened US trading week, investors have their hands full with a variety of earnings reports from various sectors.
deraktionaer.de/artikel/maerkte-forex-zinsen/hammer-handelswoche-voraus-20350842.html
With Moderna and AstraZeneca: This biotech fund has gained over 900% in the last 20 years
boerse-online.de/nachrichten/fonds/mit-moderna-und-astrazeneca-dieser-biotech-fonds-hat-in-den-letzten-20-jahren-ueber-900-zugelegt-20350596.html
EU Parliament: Agriculture should use genetic engineering - but patent-free: The European Parliament supports the use of modern plant breeding methods in ...
agrarheute.com/politik/eu-parlament-landwirtschaft-gentechnik-nutzen-ohne-patente-616191
Irish-led biotech firm Synlogic to cease operations after drug trial discontinued
businesspost.ie/tech/irish-led-biotech-firm-synlogic-to-cease-operations-after-drug-trial-discontinued/
Paid articlePaid
New medicine is needed: The pharmaceutical industry is looking for the next cash cow
faz.net/aktuell/wirtschaft/unternehmen/novartis-offerte-fuer-morphosys-die-pharmabranche-sucht-den-naechsten-goldesel-19500881.html
Paid articlePaid
Novartis acquires German biotech MorphoSys for CHF2.5 billion: Even after its numerous acquisitions in 2023, the pharmaceutical company Novartis has not yet ...
swissinfo.ch/eng/business/novartis-acquires-german-biotech-morphosys-for-chf2_5-billion/49189882
New biotech aims to alleviate suffering caused by skin diseases : Boston and Geneva-based enterprise believes new technology will transform dermatology
ft.com/content/a076888e-f6af-4a1b-8244-11a13daab778
Paid articlePaid
Everyone Wants to Live Longer. Figuring Out How Will Take Years—and Billions of Dollars.
barrons.com/articles/aging-longevity-drugs-treatments-c4849b98
Paid articlePaid Biotech Kyverna Surges 36% in Debut After Boosting IPO Size: Kyverna Therapeutics Inc. rose as much as 59% in early trading after its expanded US initial public ...
bloomberg.com/news/articles/2024-02-08/biotech-kyverna-surges-as-much-as-59-after-boosting-ipo-size
Paid articlePaid Investors pile into psychedelic drug start-ups tackling mental health : Sovereign wealth funds Temasek and Mubadala in talks to fund biotech groups harnessing ...
ft.com/content/4a2e856c-4736-4b8b-9323-583bb1dbe8f4
Paid articlePaid Amgen quarterly profit rises 15%, obesity drug trials are on track: Amgen on Tuesday said its adjusted fourth-quarter profit rose 15%, driven by a 20% increase ...
reut.rs/3HRMKJ4
Developer bows out of Oakland apartment project amid market distress: Oakland’s apartment market is struggling amid softening demand and rents — and too much ...
sfchronicle.com/realestate/article/1940-webster-oakland-18656389.php
Paid articlePaid AstraZeneca Stock Slips on Soft Earnings Report as Cancer Drug Sales Disappoint: The drugmaker AstraZeneca reported underwhelming earnings for its fourth quarter ...
barrons.com/articles/astrazeneca-earnings-stock-price-6ee446ba
Paid articlePaid How 23AndMe Went From a $6 Billion Valuation to a Penny Stock: DNA-testing company 23AndMe and its founder, Anne Wojcicki, aimed to revolutionize healthcare ...
wsj.com/video/series/news-explainers/how-23andme-went-from-a-6-billion-valuation-to-a-penny-stock/DA5354F8-9CD2-48C3-8183-BBED6EAF49FD
Boston startups funding outpace New York in 2023, new data shows: Despite a funding slowdown, Boston's startup scene is thriving, thanks to its strong biotech ...
businessinsider.com/boston-startups-outpace-new-york-funding-carta-data-shows-2024-2
Paid articlePaid Biotech IPOs Jump More Than 20% as Momentum Builds for Listings: Drug developers are capitalizing on the industry’s momentum by tapping public investors for the ...
bloomberg.com/news/articles/2024-02-07/biotech-ipos-jump-more-than-20-as-momentum-builds-for-listings
Paid articlePaid Editas Medicine, Inc. (EDIT) Guggenheim 6th Annual Biotechnology Conference (Transcript)
seekingalpha.com/article/4668283-editas-medicine-inc-edit-guggenheim-6th-annual-biotechnology-conference-transcript
China Biotech Stocks Fall on Bill Potentially Banning US Government Contracts: China’s biotech stocks faced renewed selling pressure as geopolitical concerns add ...
bloomberg.com/news/articles/2024-02-05/china-biotech-stocks-lag-benchmark-most-in-four-years-on-us-bill
Paid articlePaid Next
New to NewsWall?
Sign up now to get your own personalized news!
Trending topics